Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

March 31, 2028

Conditions
Overactive BladderUrinary Urgency IncontinenceBenign Prostatic HyperplasiaProstate CancerProstatectomyUrinary Frequency
Interventions
DEVICE

Axonics SNM System

To assess clinical outcomes of the Axonics SNM System in the male OAB population.

Trial Locations (13)

22191

RECRUITING

Potomac Urology, Woodbridge

33136

RECRUITING

University of Miami, Miami

35205

RECRUITING

University of Alabama at Birmingham, Birmingham

36532

RECRUITING

Urology Associates, Fairhope

44106

RECRUITING

University Hospitals Cleveland, Cleveland

55905

RECRUITING

Mayo Clinic, Rochester

70112

RECRUITING

Louisiana State University, New Orleans

71103

RECRUITING

WK Clinical Research, Shreveport

74104

RECRUITING

Utica Park Urology, Tulsa

76017

RECRUITING

Urology Partners of North Texas (UPNT), Arlington

77070

RECRUITING

Texas Oncology, Houston

92562

RECRUITING

Tri Valley Urology, Murrieta

94040

RECRUITING

El Camino Health, Mountain View

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Axonics, Inc.

INDUSTRY

NCT06511141 - Sacral Neuromodulation for Male Overactive Bladder (MOAB) | Biotech Hunter | Biotech Hunter